Sino Biopharmaceutical | 1177 - Ebitda

Stock Price
6.39
Daily Change
-0.45 -6.58%
Monthly
-1.99%
Yearly
91.32%
Q1 Forecast
6.38

Sino Biopharmaceutical reported CNY2.59B in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -21.9M 12.04M Jun/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Jiangsu Hengrui CNY 2.98B 890.87M Jun/2025
Moderna USD -790M 582M Dec/2025
Organon & Co USD 383M 135M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Tectonic Therapeutic USD -13.48M 5.73M Dec/2024
Viatris USD 1.15B 75.8M Sep/2025
Xeris Pharmaceuticals USD 17.42M 8.83M Sep/2025